Twenty-one of these patients (14% pediatric, 52% female) were found to have MOG antibody positivity on testing: 14 by live assay only, 3 by fixed assay only and 4 by both, representing 14% of patients who were clinically suspicious for NMO and seronegative for AQP4 antibodies. Here, MOG is linked to neuromyelitis optica.